Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
RSS

FDA approves Absorica for severe recalcitrant nodular acne

May 29, 2012

Confirmatory U.S. phase III trial of Scenesse begins

May 23, 2012

A new small molecule inhibits dermal inflammation in mouse models

May 23, 2012

Fibrocell Science enters two new agreements

May 17, 2012

Fibrocell Science submits protocol to FDA for azficel-T study

May 15, 2012

Japanese authorities lift approval condition and extend label for Remicade

May 9, 2012

Reimbursement allows early availability of Scenesse in Switzerland

April 26, 2012

Kythera Biopharmaceuticals reports on European ATX-101 studies

April 26, 2012

Adocia reports phase II results for diabetic foot ulcer treatment

April 25, 2012

Recruitment complete in phase II studies of Levulan Kerastick PDT

April 25, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 21, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
LIT-002 is strong candidate for autism and neuropathic pain
BioWorld Science
Researchers from the University of Strasbourg and the Centre National de la Recherche Scientifique (CNRS) have presented data on LIT-002, a nonpeptide oxytocin...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
Anle-138b reduces mHTT aggregation, improves pathological phenotypes in Huntington’s models
BioWorld Science
Anle-138b (emrusolmin) is a diphenylpyrazole compound that directly interacts with oligomeric species of disease-related aggregating proteins, reducing aggregate...